High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysis.

Source:http://linkedlifedata.com/resource/pubmed/id/19100397

Download in:

View as

Triples

General Info

PMID
19100397